about
Dimension of model parameter space and operating characteristics in adaptive dose-finding studies.Integrating the escalation and dose expansion studies into a unified Phase I clinical trial.Sequential monitoring of Phase I dose expansion cohorts.Design considerations for early-phase clinical trials of immune-oncology agents
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose expansion cohorts in Phase I trials.
@en
Dose expansion cohorts in Phase I trials.
@nl
type
label
Dose expansion cohorts in Phase I trials.
@en
Dose expansion cohorts in Phase I trials.
@nl
prefLabel
Dose expansion cohorts in Phase I trials.
@en
Dose expansion cohorts in Phase I trials.
@nl
P2860
P1476
Dose expansion cohorts in Phase I trials.
@en
P2093
Alexia Iasonos
John O'Quigley
P2860
P304
P356
10.1080/19466315.2015.1135185
P577
2016-06-02T00:00:00Z